Perrigo Company plc (PRGO)
NYSE: PRGO · IEX Real-Time Price · USD
31.02
-0.09 (-0.29%)
At close: May 9, 2024, 4:00 PM
30.61
-0.41 (-1.32%)
After-hours: May 9, 2024, 7:08 PM EDT
Perrigo Company Employees
Perrigo Company had 9,140 employees on December 31, 2023. The number of employees increased by 240 or 2.70% compared to the previous year.
Employees
9,140
Change (1Y)
240
Growth (1Y)
2.70%
Revenue / Employee
$498,457
Profits / Employee
-$842
Market Cap
4.20B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9,140 | 240 | 2.70% |
Dec 31, 2022 | 8,900 | -1,000 | -10.10% |
Dec 31, 2021 | 9,900 | -1,600 | -13.91% |
Dec 31, 2020 | 11,500 | 300 | 2.68% |
Dec 31, 2019 | 11,200 | 600 | 5.66% |
Dec 31, 2018 | 10,600 | 200 | 1.92% |
Dec 31, 2017 | 10,400 | -2,400 | -18.75% |
Dec 31, 2016 | 12,800 | -500 | -3.76% |
Dec 31, 2015 | 13,300 | 3,080 | 30.14% |
Jun 28, 2014 | 10,220 | 320 | 3.23% |
Aug 9, 2013 | 9,900 | 1,100 | 12.50% |
Aug 10, 2012 | 8,800 | 100 | 1.15% |
Aug 9, 2011 | 8,700 | 1,000 | 12.99% |
Aug 9, 2010 | 7,700 | 450 | 6.21% |
Aug 10, 2009 | 7,250 | 1,050 | 16.94% |
Aug 8, 2008 | 6,200 | 0 | - |
Jun 30, 2007 | 6,200 | 231 | 3.87% |
Jul 1, 2006 | 5,969 | 121 | 2.07% |
Jun 25, 2005 | 5,848 | 3,138 | 115.79% |
Jun 26, 2004 | 2,710 | -115 | -4.07% |
Jun 28, 2003 | 2,825 | -172 | -5.74% |
Jun 29, 2002 | 2,997 | -317 | -9.57% |
Jun 30, 2001 | 3,314 | -228 | -6.44% |
Jul 1, 2000 | 3,542 | -649 | -15.49% |
Jul 3, 1999 | 4,191 | -677 | -13.91% |
Jun 30, 1998 | 4,868 | 756 | 18.39% |
Jun 30, 1997 | 4,112 | 76 | 1.88% |
Jun 30, 1996 | 4,036 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Select Medical Holdings | 54,600 |
Integer Holdings | 10,500 |
RadNet | 7,872 |
Oscar Health | 2,400 |
Alkermes | 2,100 |
Insmed | 912 |
TransMedics Group | 584 |
Iovance Biotherapeutics | 557 |
PRGO News
- 2 days ago - Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations - PRNewsWire
- 2 days ago - Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business - PRNewsWire
- 8 days ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 14 days ago - Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million - PRNewsWire
- 16 days ago - Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024 - PRNewsWire
- 5 weeks ago - CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors - Reuters
- 2 months ago - Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States - PRNewsWire
- 2 months ago - Perrigo to Attend UBS Global Consumer and Retail Conference - PRNewsWire